12-month outcomes of the US patient cohort in the SONATA pivotal IDE trial of transcervical ablation of uterine fibroids

OBJECTIVE: The prospective SONATA pivotal Investigational Device Exemption (IDE) trial was performed in the United States (US) and Mexico to examine the safety and effectiveness of transcervical fibroid ablation (TFA) in the treatment of symptomatic uterine fibroids. This is an analysis of 12-month...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Int J Womens Health
Auteurs principaux: Hudgens, Joseph, Johns, D Alan, Lukes, Andrea S, Forstein, David A, Delvadia, Dipak
Format: Artigo
Langue:Inglês
Publié: Dove 2019
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6616301/
https://ncbi.nlm.nih.gov/pubmed/31308763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJWH.S201912
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires